Invex Therapeutics Ltd
ASX:IXC
Invex Therapeutics Ltd
ASX:IXC
Price:
0.11
AUD
-12%
Market Closed
Market Cap:
AU$8.3m
Cash Flow Statement
Cash Flow Statement
Invex Therapeutics Ltd
Invex Therapeutics Ltd
Currency: AUD
| Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Stock-Based Compensation |
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
1
|
0
|
|
| Cash from Operating Activities |
(2)
N/A
|
(2)
-32%
|
(3)
-52%
|
(6)
-76%
|
(7)
-16%
|
(5)
+23%
|
(2)
+54%
|
(0)
+85%
|
(1)
-76%
|
|
| Financing Cash Flow | ||||||||||
| Net Issuance of Common Stock |
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other |
(1)
|
0
|
0
|
0
|
0
|
(14)
|
(14)
|
0
|
0
|
|
| Cash from Financing Activities |
8
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
(14)
N/A
|
(14)
N/A
|
0
N/A
|
0
N/A
|
|
| Change in Cash | ||||||||||
| Effect of Foreign Exchange Rates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Change in Cash |
6
N/A
|
(2)
N/A
|
(3)
-52%
|
(6)
-76%
|
(7)
-16%
|
(19)
-181%
|
(16)
+15%
|
(0)
+98%
|
(1)
-88%
|
|
| Free Cash Flow | ||||||||||
| Free Cash Flow |
(2)
N/A
|
(2)
-32%
|
(3)
-52%
|
(6)
-76%
|
(7)
-16%
|
(5)
+23%
|
(2)
+54%
|
(0)
+85%
|
(1)
-76%
|
|
Switch to:
Switch to:
See Also
Discover More
